Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001193125-26-173766
Filing Date
2026-04-23
Accepted
2026-04-23 16:20:10
Documents
1
Period of Report
2026-04-21

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 4294
  Complete submission text file 0001193125-26-173766.txt   5725
Mailing Address 12750 HIGH BLUFF DRIVE SUITE 475 SAN DIEGO CA 92130
Business Address 12750 HIGH BLUFF DRIVE SUITE 475 SAN DIEGO CA 92130 858-246-6240
BELITE BIO, INC (Issuer) CIK: 0001889109 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address GOTTHARDSTRASSE 26 ZUG Switzerland 6300
Business Address
Scholl Hendrik Peter (Reporting) CIK: 0002113223 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41359 | Film No.: 26888934